Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
Authors:
Open Access
- 1 January 2011
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2011 (1) , 841564
Abstract
Tanshinone IIA (Tan IIA) and sodium tanshinone IIA sulfonate (STS) were found to have protective effects on cardiomyocyte against adriamycin‐induced damage and may be used clinically. It is unclear whether the supplementation of STS or Tan IIA would affect the anticancer activity of anthracycline. To evaluate the effect of Tan IIA or STS on the anticancer of epirubicin, the cell viability, apoptosis, Akt expression, and uptake of epirubicin after supplementation of Tan IIA or STS in the epirubicin‐treated BT‐20 cells were measured and compared. Tan IIA inhibited BT‐20 cell growth and induced apoptosis in a time‐ and dose‐dependent manner. When Tan IIA was used with epirubicin, an increase of BT‐20 cells apoptosis was accompanied by the decreasing phosphorylation of Akt. STS had no effect on the cell viability of BT‐20 cells. However, when used with epirubicin, STS decreased the epirubicin‐induced cytotoxicity and apoptosis in BT‐20 cells. The antagonistic effect of STS on epirubicin‐induced cytotoxicity in BT‐20 cells occurred concomitantly with the reduced epirubicin uptake and the increased phosphorylation of Akt. STS decreased the uptake of epirubicin in BT‐20 cells and blocked epirubicin‐induced apoptosis through activation of Akt.Keywords
This publication has 36 references indexed in Scilit:
- Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapyPharmacology & Therapeutics, 2010
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009Annals of Oncology, 2009
- Sodium Tanshinone IIA Sulfonate Protects Cardiomyocytes Against Oxidative Stress-mediated Apoptosis Through Inhibiting JNK ActivationJournal of Cardiovascular Pharmacology, 2008
- Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathwayExperimental & Molecular Medicine, 2007
- Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategiesBritish Journal of Haematology, 2005
- Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cellsJournal of Biomedical Science, 2005
- HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cellsOncogene, 2003
- Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques: Table 1Heart, 2002
- Determination and reversal of resistance to epirubicin intravesical chemotherapy. A flow cytometric modelBritish Journal of Urology, 1996
- Anthracycline Antibiotics in Cancer TherapyDrugs, 1994